PubMed Health⌕ Search

PubMed · 10827487

[Analytical uncertainty--how wrong can a laboratory result be?].

Abstract

Some uncertainty encumbers the outcome of all laboratory tests. Patient conditions and handling of specimens, as well as analytical variation and systematic error will affect the results. In order not to confuse the interpretation of test results, the analytical standard deviation should not exceed one half of the intraindividual biological standard deviation, and systematic error should not exceed 1/16 of the reference interval. However, these goals cannot always be achieved. Moreover, analytical control procedures have limited ability to detect errors in the analytical process. After one analysis of control material, using +/- 2 standard deviations (analytical) from the mean as acceptance limits, the magnitude of a systematic error must be 3.3 times the analytical standard deviation in order to be detected with 90% probability. As a result of such error, patients' results can be released with a total error up to five times the analytical standard deviation. More complicated control procedures may give smaller total error. Practising physicians should be familiar with the variations in lab results, and interpret the results accordingly. Lab results that conflict with results of other investigations should be used with caution.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B J Bolann, B Stølsnes. 1999-12-10. [Analytical uncertainty--how wrong can a laboratory result be?].. https://pubmed.ncbi.nlm.nih.gov/10827487/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.

Blood Chemical Analysis↗